Evidence map›Paper›PMID 37938365›Full record

ArticleJournal of plant research2024

Integrative transcriptomic and metabolomic analyses reveal the phenylpropanoid and flavonoid biosynthesis of Prunus mume.

Rui Wu, Chengcheng Qian, Yatian Yang, Yi Liu, Liang Xu, Wei Zhang, Jinmei Ou

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of plant research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Prunin: An Emerging Anticancer Flavonoid.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rui WuSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
Chengcheng QianSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
Yatian YangSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
Yi LiuSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
Liang XuSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
Wei ZhangSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China. zhangwei@ahtcm.edu.cn.
Jinmei OuSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China. toojm9319@163.com.ORCID http://orcid.org/0000-0002-9336-8781

Funding

Ability Establishment of Sustainable Use for Valuable Chinese medicine Resources 2060302Research Project on Pharmacodynamic Material Basis of Anhui Genuine Main Medicinal Materials RZ2100000757Scientific Research Project of University of Anhui Province 2023AH050787Talent Project of Anhui University of Chinese Medicine 2021RCYB011
6 · The paper itself

Abstract

Prunus mume is an important medicinal plant with ornamental and edible value. Its flowers contain phenylpropanoids, flavonoids and other active components, that have important medicinal and edible value, yet their molecular regulatory mechanisms in P. mume remain unclear. In this study, the content of total flavonoid and total phenylpropanoid of P. mume at different developmental periods was measured first, and the results showed that the content of total flavonoid and total phenylpropanoid gradually decreased in three developmental periods. Then, an integrated analysis of transcriptome and metabolome was conducted on three developmental periods of P. mume to investigate the law of synthetic accumulation for P. mume metabolites, and the key enzyme genes for the biosynthesis of phenylpropanoids and flavonoids were screened out according to the differentially expressed genes (DEGs). A total of 14,332 DEGs and 38 differentially accumulate metabolites (DAMs) were obtained by transcriptomics and metabolomics analysis. The key enzyme genes and metabolites in the bud (HL) were significantly different from those in the half-opening (BK) and full-opening (QK) periods. In the phenylpropanoid and flavonoid biosynthesis pathway, the ion abundance of chlorogenic acid, naringenin, kaempferol, isoquercitrin, rutin and other metabolites decreased with the development of flowers, while the ion abundance of cinnamic acid increased. Key enzyme genes such as HCT, CCR, COMT, CHS, F3H, and FLS positively regulate the downstream metabolites, while PAL, C4H, and 4CL negatively regulate the downstream metabolites. Moreover, the key genes FLS (CL4312-2, CL4312-3, CL4312-4, CL4312-5, CL4312-6) regulating the synthesis of flavonols are highly expressed in bud samples. The dynamic changes of these metabolites were validated by determining the content of 14 phenylpropanoids and flavonoids in P. mume at different developmental periods, and the transcription expression levels of these genes were validated by real-time PCR. Our study provides new insights into the molecular mechanism of phenylpropanoid and flavonoid accumulation in P. mume.

Indexed as

PrunusTranscriptomeFlavonoidsFlowersGene Expression ProfilingGene Expression Regulation, PlantFlavonoidsFlavonoidsMetabolomicsPhenylpropanoidsPrunus mumeTranscriptomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.